435 related articles for article (PubMed ID: 18600597)
1. Drug development for children: how is pharma tackling an unmet need?
Hawcutt DB; Smyth RL
IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
[TBL] [Abstract][Full Text] [Related]
2. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
3. Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
[TBL] [Abstract][Full Text] [Related]
4. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
5. Towards evidence-based pharmacotherapy in children.
Kemper EM; Merkus M; Wierenga PC; Van Rijn PC; Van der Werff D; Lie-A-Huen L; Offringa M
Paediatr Anaesth; 2011 Mar; 21(3):183-9. PubMed ID: 21199133
[TBL] [Abstract][Full Text] [Related]
6. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
Vassal G
Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
[TBL] [Abstract][Full Text] [Related]
7. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
Beecher N
IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
[No Abstract] [Full Text] [Related]
9. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
10. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
[TBL] [Abstract][Full Text] [Related]
11. Partnership between small biotech and big pharma.
Wiederrecht GJ; Hill RG; Beer MS
IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
[TBL] [Abstract][Full Text] [Related]
12. [Children on the drug development map. The Danish Society of Clinical Pharmacology].
Thirstrup S; Heisterberg J;
Ugeskr Laeger; 2008 Mar; 170(12):1039. PubMed ID: 18397657
[No Abstract] [Full Text] [Related]
13. Involving the pharmaceutical and biotech communities in medication development for substance abuse.
Gorodetzky CW; Grudzinskas C
Pharmacol Ther; 2005 Oct; 108(1):109-18. PubMed ID: 16038981
[TBL] [Abstract][Full Text] [Related]
14. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
Mentzer D
Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
[TBL] [Abstract][Full Text] [Related]
15. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
16. If children ruled the pharmaceutical industry: the need for pediatric formulations.
Rieder M
Drug News Perspect; 2010 Sep; 23(7):458-64. PubMed ID: 20862398
[TBL] [Abstract][Full Text] [Related]
17. [Are children getting the right drugs?].
Bratlid D
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
[TBL] [Abstract][Full Text] [Related]
18. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
[TBL] [Abstract][Full Text] [Related]
19. Medicines regulation and health technology assessment.
Breckenridge A; Woods K; Walley T
Clin Pharmacol Ther; 2010 Feb; 87(2):152-4. PubMed ID: 20107448
[TBL] [Abstract][Full Text] [Related]
20. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
Reeve LM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
